Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test.
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...